Observe Medical Asa Cash Flow Conversion Efficiency

Latest as of December 2025: -0.829x

Observe Medical Asa cash flow conversion efficiency. Based on the latest financial reports, Observe Medical Asa (OBSRV) has a cash flow conversion efficiency ratio of -0.829x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-24.83 Million ≈ $-2.61 Million USD) by net assets (Nkr29.96 Million ≈ $3.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Observe Medical Asa (2016–2025)

Cash flow conversion efficiency of Observe Medical Asa from 2016 to 2025. This chart illustrates how Observe Medical Asa's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Observe Medical Asa for real-time trading data and today's change.

Observe Medical Asa Cash Flow Conversion Ratio Explained

Observe Medical Asa cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Observe Medical Asa Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Observe Medical Asa ranked by their cash flow conversion efficiency. Also see OBSRV market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Rayong Wire Industries Public Company Limited
BK:RWI
-0.006x
Mida Leasing Public Company Limited
BK:ML
0.018x
Ganges Securities Limited
NSE:GANGESSECU
0.035x
Vo2 Cap Holding AB
ST:VO2
0.045x
Prg Holdings Bhd
KLSE:7168
-0.011x
Prochem S.A.
WAR:PRM
0.055x
BALAXI PHARMACEUTICALS LIMITED
NSE:BALAXI
0.060x
GreenPro Capital Corp
NASDAQ:GRNQ
-0.061x

Annual Cash Flow Conversion Efficiency for Observe Medical Asa (2016–2025)

The table below shows the annual cash flow conversion efficiency of Observe Medical Asa from 2016 to 2025. Review OBSRV financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Nkr29.96 Million
≈ $3.15 Million
Nkr-24.83 Million
≈ $-2.61 Million
-0.829x +34.86%
2024-12-31 Nkr24.11 Million
≈ $2.54 Million
Nkr-30.68 Million
≈ $-3.23 Million
-1.273x -483.24%
2023-12-31 Nkr112.08 Million
≈ $11.79 Million
Nkr-24.45 Million
≈ $-2.57 Million
-0.218x +41.25%
2022-12-31 Nkr138.31 Million
≈ $14.55 Million
Nkr-51.37 Million
≈ $-5.41 Million
-0.371x -123.71%
2021-12-31 Nkr-14.12 Million
≈ $-1.49 Million
Nkr-22.13 Million
≈ $-2.33 Million
1.567x +247.31%
2020-12-31 Nkr20.35 Million
≈ $2.14 Million
Nkr-21.64 Million
≈ $-2.28 Million
-1.064x -10.69%
2019-12-31 Nkr14.54 Million
≈ $1.53 Million
Nkr-13.97 Million
≈ $-1.47 Million
-0.961x -93.26%
2018-12-31 Nkr16.82 Million
≈ $1.77 Million
Nkr-8.36 Million
≈ $-880.11K
-0.497x +42.36%
2017-12-31 Nkr11.39 Million
≈ $1.20 Million
Nkr-9.83 Million
≈ $-1.03 Million
-0.863x -21.31%
2016-12-31 Nkr14.70 Million
≈ $1.55 Million
Nkr-10.45 Million
≈ $-1.10 Million
-0.711x --

About Observe Medical Asa

OL:OBSRV Norway Medical Devices
Market Cap
$12.26 Million
Nkr116.54 Million NOK
Market Cap Rank
#26384 Global
#241 in Norway
Share Price
Nkr0.86
Change (1 day)
-2.51%
52-Week Range
Nkr0.56 - Nkr1.25
All Time High
Nkr34.00
About

Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a dig… Read more